This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Health Stocks in Motion

Updated from 3:06 p.m. EDT

Shares of Merit Medical Systems (MMSI) were among the worst-performing health and pharmaceutical stocks Wednesday, falling 15% after the company warned that third-quarter earnings and sales would fall below Wall Street expectations.

The maker of disposable medical products expects earnings of 14 cents to 15 cents a share on sales of $35 million to $36 million. Analysts polled by Thomson First Call had been expecting earnings of 19 cents a share on sales of $39.1 million. The company said the shortfall in earnings and sales was caused by reduced demand for its products during the quarter, which it attributed to an increase in competition, fewer procedures being conducted using its products, and -- to a lesser extent -- weather-related disturbances in the southeastern United States. Shares traded down $2.14 to $12.05.

Cell Genesys (CEGE) fell 12.8% after the biotechnology company released preliminary third-quarter results and said it would sell $100 million in convertible notes. The company expects to post a third-quarter loss of 52 cents a share on sales of $3.2 million. Analysts had been expecting a loss of 52 cents a share on sales of $3.25 million. As for the convertible debt offering, the company said it plans to use the proceeds to repay two outstanding loans totaling $95 million. The debt repayment will eliminate restrictions on the company's $60 million cash balance. Shares traded down $1.09 to $7.42.

Shares of aaiPharma (AAII) rose 0.5% after the company announced its lenders waived compliance for certain covenants in the company's senior secured credit facility. The waiver covers the quarters ending Sept. 30 and Dec. 31, respectively, and is contingent upon the company meeting minimum EBITDA thresholds. Earlier this month, the company missed an interest payment of $10 million on its 11.5% senior subordinated notes due 2010. Shares traded up 1 cent to $1.95.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs